[{"NetIncomeLoss_1_Q1_USD":-30694000.0,"OperatingLeasesRentExpenseNet_1_Q1_USD":500000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-82000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-186220000.0,"Depreciation_1_Q1_USD":108000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":22139000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1558000.0,"AssetsCurrent_0_Q1_USD":610705000.0,"LongTermDebtCurrent_0_Q1_USD":3000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":6834000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":829000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2080000.0,"CommonStockSharesIssued_0_Q1_shares":66263000.0,"Assets_0_Q1_USD":620263000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-128000.0,"ShareBasedCompensation_1_Q1_USD":5075000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":5949000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"InterestAndOtherIncome_1_Q1_USD":302000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":750000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":149500000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":66218000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-410000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":20324000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":8072000.0,"CommonStockValue_0_Q1_USD":7000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-1452000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":79000.0,"RestrictedCash_0_Q1_USD":210000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":36969000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-30822000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":110835000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":5196000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":919258000.0,"Liabilities_0_Q1_USD":34276000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":46000.0,"OperatingLeaseLiability_0_Q1_USD":7298000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":10572000.0,"OtherAssetsNoncurrent_0_Q1_USD":1330000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":774000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":722000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2860000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5075000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_0_Q1_security":16.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-28517000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":310200000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":2098000.0,"LiabilitiesCurrent_0_Q1_USD":25139000.0,"AccountsPayableCurrent_0_Q1_USD":958000.0,"NonoperatingIncomeExpense_1_Q1_USD":202000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":394000.0,"InterestExpense_1_Q1_USD":108000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":6832000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":829000.0,"LongTermDebtNoncurrent_0_Q1_USD":3500000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1771000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.055,"OperatingLeasePayments_1_Q1_USD":500000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2069000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":111045000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1614000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":223158000.0,"CommonStockSharesOutstanding_0_Q1_shares":66263000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":493038000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":620263000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3858000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":2463000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2102000.0,"RestrictedCashNoncurrent_0_Q1_USD":210000.0,"OperatingExpenses_1_Q1_USD":30896000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.46,"OtherLiabilitiesNoncurrent_0_Q1_USD":441000.0,"StockholdersEquity_0_Q1_USD":585987000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":31000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-850000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-333196000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-214658000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_1_Q1_USD":0.0,"Ticker":"KURA","CIK":"1422143","name":"KURA ONCOLOGY, INC.","OfficialName":"Kura Oncology Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1071823749.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]